Farther Finance Advisors
AKTS icon

Farther Finance Advisors’s Aktis Oncology AKTS Stock Holding History

Farther Finance Advisors’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.37K Buy
173
+96
+125% +$2.34K ﹤0.01% 5194
2026
Q2 		$2.41K Buy
+77
New +$1.58K ﹤0.01% 5107

Other funds holding AKTS

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors's AKTS Position: Q3 2026 in Review

Farther Finance Advisors increased its Aktis Oncology (AKTS) stake by 125% in Q3 2026, buying an estimated $2.34K and bringing the position to 173 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #5194.

Farther Finance Advisors first reported a position in AKTS in Q2 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • Farther Finance Advisors held 173 shares of Aktis Oncology worth $3.37K as of Q3 2026.
  • Farther Finance Advisors bought 96 Aktis Oncology shares in Q3 2026, an estimated $2.34K.
  • Aktis Oncology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5194 holding.
  • Farther Finance Advisors first reported a position in Aktis Oncology in Q2 2026 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.